Last reviewed · How we verify

NCT03369145: OVEREAT

High-fat Overfeeding, Hepatokines and Appetite Regulation

Completed NA Last updated 18 February 2019
What this trial tests

NA trial testing High-fat diet in Insulin Resistance in 12 participants. Completed in 31 July 2018.

Timeline
11 December 2017
Primary endpoint
31 July 2018
31 July 2018

Quick facts

Lead sponsorLoughborough University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposebasic science
Enrollment12
Start date11 December 2017
Primary completion31 July 2018
Estimated completion31 July 2018
Sites2 locations across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Loughborough University

Who can join

Adults 18 to 40, male only, with Insulin Resistance or Type2 Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study will investigate the effect of high-fat overfeeding on a group of liver-secreted proteins linked to worsened blood sugar control, as well as proteins involved in appetite control. Participants will consume both a high-fat diet, consisting of 50% extra calories above their daily required intake, and a control diet, consisting of their normal 'habitual' diet, with each diet lasting seven days. The diets will be undertaken in a randomised order, with a period of three weeks separating the two diets. Blood samples will be taken before and after each diet to measure blood sugar control. Further blood samples will also be taken 24 hours and 72 hours into each diet to see how levels of the liver and appetite-regulating proteins change over the course of the seven days. It is expected that blood sugar control will be worsened by the high-fat diet and this will be accompanied by increases in levels of the liver-secreted proteins and an impaired release of the appetite-regulating proteins into the blood.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Acute Hyperenergetic, High-Fat Feeding Increases Circulating FGF21, LECT2, and Fetuin-A in Healthy Men.
    Willis SA, Sargeant JA, Yates T, Takamura T, et al · · 2020 · cited 26× · PMID 31919514 · DOI 10.1093/jn/nxz333
  2. Influence of Short-Term Hyperenergetic, High-Fat Feeding on Appetite, Appetite-Related Hormones, and Food Reward in Healthy Men.
    Thackray AE, Willis SA, Clayton DJ, Broom DR, et al · · 2020 · cited 4× · PMID 32872401 · DOI 10.3390/nu12092635

Verify or expand the search:

Other trials of High-fat diet

Trials testing the same drug.

Other recruiting trials for Insulin Resistance

Currently open trials in the same condition.

Other Loughborough University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03369145.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing